DP
RMD icon

Dundas Partners’s ResMed RMD Stock Holding History

Dundas Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.6M Hold
203,021
– – 2.86% 14
2026
Q1 		$45.6M Sell
203,021
-1,941
-0.9% -$484K 3.63% 11
2025
Q4 		$49.4M Buy
204,962
+29,845
+17% +$7.63M 3.48% 14
2025
Q3 		$47.9M Buy
175,117
+22,933
+15% +$6.26M 3.38% 12
2025
Q2 		$39.3M Hold
152,184
– – 2.73% 16
2025
Q1 		$34.1M Buy
152,184
+11,622
+8% +$2.71M 2.51% 20
2024
Q4 		$32.1M Hold
140,562
– – 2.25% 26
2024
Q3 		$34.3M Buy
140,562
+7,875
+6% +$1.76M 2.47% 22
2024
Q2 		$25.4M Buy
132,687
+23,819
+22% +$4.83M 1.97% 27
2024
Q1 		$21.6M Buy
+108,868
New +$19.9M 1.7% 31

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dundas Partners's RMD Position: Q2 2026 in Review

Dundas Partners held its ResMed (RMD) position steady in Q2 2026 at 203,021 shares worth $39.6M. The position accounts for 2.86% of the portfolio, ranked #14.

Dundas Partners first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $49.4M in Q4 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Dundas Partners held 203,021 shares of ResMed worth $39.6M as of Q2 2026.
  • Dundas Partners left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 2.86% of Dundas Partners's portfolio in Q2 2026, its #14 holding.
  • Dundas Partners first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Dundas Partners's ResMed position peaked at $49.4M in Q4 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Dundas Partners's 13F filing for Q2 2026, filed 14 Aug 2026.